How much has Enlaza Therapeutics raised?
$176.0Macross 3 recorded rounds · Mar 2021 – Aug 2025
Most recently, Enlaza Therapeutics raised $15.0M in its Early Stage VC (Aug 2025).
Free account
More of Enlaza Therapeutics with a free account
- ·The complete investor list: 13 names
- ·Watch Enlaza Therapeutics: the Monday email on marks, rounds and moves
Enlaza Therapeutics round by round
3 rounds1 investors participated
16 investors participated
10 investors participated
How much has Enlaza Therapeutics raised?
Enlaza Therapeutics has raised $176 million across 3 recorded rounds since 2021. The largest was an $84 million later-stage round in Apr 2024; the most recent was a $15 million early-stage round in Aug 2025.
Enlaza Therapeutics has filed 8 Form Ds with the SEC since 2021, most recently in Sep 2025 ($15 million sold to 1 investor).
Enlaza Therapeutics investors
13 investors are on record for Enlaza Therapeutics, including Lightspeed Venture Partners, Alexandria Venture Investments, Samsara BioCapital and Pfizer Ventures. The early-stage round in Aug 2025 drew 1 investor.
For fundraisers
Raising for a company like Enlaza Therapeutics?
13 investors have backed Enlaza Therapeutics.
Frequently asked about Enlaza Therapeutics
- How much has Enlaza Therapeutics raised?
- Enlaza Therapeutics has raised $176.0M in total across 3 recorded funding rounds.
- When was Enlaza Therapeutics's last funding round?
- Enlaza Therapeutics's most recent recorded round was Early Stage VC in Aug 2025, raising $15.0M.